ArticleAbdominal radiology (New York)2026
Interpretable prediction of occult lymph node metastasis in pancreatic ductal adenocarcinoma using a model fusing habitat radiomics and deep learning.
Article in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeTo evaluate the value of integrating habitat radiomics features and deep learning features for predicting occult lymph node metastasis (OLNM) in pancreatic ductal adenocarcinoma (PDAC).
methodsData from 212 eligible PDAC patients across two institutions were analyzed. Cohorts were allocated as follows: training (n = 115), internal validation (n = 50), and external validation (n = 47). Habitat subregion partitioning of the tumor volume of interest (VOI) from portal venous phase computed tomography images was performed using a K-means clustering algorithm, and radiomics features were subsequently extracted. A 2.5D deep learning model based on ResNet18 was used to extract features from the whole VOI. After feature selection, models based on single-feature types and a fusion model integrating habitat radiomics features and deep learning features were developed. Model performance was assessed using receiver operating characteristic curves, decision curve analysis (DCA), and calibration curves. Model interpretability was evaluated via SHapley Additive exPlanations (SHAP).
resultsRelative to single-feature-based models, the fusion model achieved superior predictive performance with an area under the curve (AUC) of 0.832 (95% CI: 0.712-0.951) in the external validation cohort. DCA and calibration curves revealed that this model provided greater net clinical benefit compared with other models and demonstrated good calibration. SHAP analysis indicated that deep learning features were the top and third most important predictors.
conclusionThe fusion model exhibited favorable predictive performance for preoperative OLNM diagnosis in PDAC and represents a promising auxiliary tool for personalized therapeutic decision-making.
Indexed as
Identifiers
41973202What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.